Since approximately 74.8% (131/175) of all anti-cancer drugs approved either have been isolated from natural sources or mimic them in one form or another (1981–2010) [16,17], agents derived from natural sources could be one potential source of STAT3 inhibitors for targeting the proliferation and survival of tumor cells [18,19,20,21]. Here, STAT3 is linked to cancer.